AllAnalyst Report
Morningstar•September 25, 2024
Morningstar•September 25, 2024Koninklijke Philips N.V.: Philips' Diagnostic Imaging Business on the Path to Growth
Summary
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal h
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- Analyst Report: Smith & Nephew plcSep 25, 2024 •
SNN
- Analyst Report: Novartis AGSep 25, 2024 •
NVS
- Analyst Report: Baxter International Inc.Sep 25, 2024 •
BAX
- Market Update: BAX, DKSSep 25, 2024 •
BAX, DKS
- Weekly Stock ListSep 23, 2024 •
LMT, NOC, HON, GEV, EMR, FDX, GE
Analyst Profile
Alex Morozov
Regional DirectorAlex Morozov, CFA, is director of European equity research for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. He leads a team of equity analysts based in Europe who cover European and global companies across all major sectors of the economy.Before assuming his current role in 2014, Morozov was head of global healthcare equity research. Previously, he was a senior equity analyst, covering the medical instruments, life sciences, and diagnostics industries. Before joining Morningstar in 2006, Morozov worked in the insurance industry.Morozov holds a bachelor’s degree in finance, with a minor in mathematics, from the University of Missouri. He also holds the Chartered Financial Analyst® designation.